Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8th edition of the American Joint Committee on Cancer staging system

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 46

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Dec 14, 2019; 25(46): 6752-6766
Published online Dec 14, 2019. doi: 10.3748/wjg.v25.i46.6752

Table 1 Characteristics of patients enrolled in this study, n (%)

Characteristic	SEER database			West China Hospital database
Characteristic	MPV- group	MPV+ group	P value	MPV- group	MPV+ group	P value
Sample size, n	6825	714		579	110
Sex			0.041^a			0.353
Male	3458 (50.7)	333 (46.6)		368 (63.6)	75 (68.2)
Female	3367 (49.3)	381 (53.4)		211 (36.4)	35 (31.8)
Age at diagnosis (± SEM)	66.4 (± 0.13)	65.4 (± 0.38)	0.019^a	58.4 (± 0.41)	58.35 (± 0.88)	0.998
Tumor diameter			0.000^a			0.003^a
≤ 2 cm	1232 (18.1)	62 (8.7)		130 (22.5)	12 (10.9)
> 2 cm but ≤ 4 cm	4377 (64.1)	482 (67.5)		373 (64.4)	73 (66.4)
> 4 cm	1216 (17.8)	170 (23.8)		76 (13.1)	25 (22.7)
Positive lymph nodes			0.161			0.001^a
0	1900 (27.8)	214 (30.0)		345 (59.6)	46 (41.8)
1-3	2893 (42.4)	311 (43.6)		195 (33.7)	48 (43.6)
≥ 4	2032 (29.8)	189 (26.5)		39 (6.7)	16 (14.5)
AJCC 8^th stage			0.000^a			0.000^a
IA	500 (7.3)	22 (3.1)		89 (15.4)	4 (3.6)
IB	1162 (17.0)	19 (20.9)		219 (37.8)	31 (28.2)
IIA	238 (3.5)	43 (6.0)		37 (6.4)	11 (10.0)
IIB	2893 (42.4)	311 (43.6)		195 (33.7)	45 (43.6)
III	2032 (29.8)	189 (26.5)		39 (6.7)	16 (14.5)
Perineural invasion			N/A			0.016^a
Absent	N/A	N/A		165 (28.3)	19 (17.3)
Present	N/A	N/A		415 (71.7)	91 (82.7)
Intravascular tumor emboli			N/A			0.971
Absent	N/A	N/A		494 (85.3)	94 (85.5)
Present	N/A	N/A		85 (14.7)	16 (14.5)
Grade¹			0.605			0.984
Well differentiated	632 (9.3)	59 (8.3)		5 (0.9)	1 (1.0)
Moderately differentiated	3397 (49.8)	314 (44.0)		215 (38.1)	37 (37.4)
Poorly/undifferentiated	2489 (36.5)	251 (35.1)		344 (61.0)	61 (61.6)
Unknown	307 (4.5)	90 (12.6)		0 (0.0)	0 (0.0)
Margin status²			N/A			0.000^a
R0	N/A	N/A		427 (73.7)	61 (55.5)
R1	N/A	N/A		152 (26.3)	49 (44.5)
R2	N/A	N/A		0 (0.0)	0 (0.0)

¹Row "Unknown" was excluded from the crosstab chi-square analysis.

²The last row was excluded from the crosstab chi-square analysis since the expected frequencies were equal to 0.

^aP < 0.05. SEER: Surveillance, epidemiology, and end results; MPV: Mesenterico-portal vein; SEM: Standard error of the mean; N/A: Not available.

Citation: Chen HY, Wang X, Zhang H, Liu XB, Tan CL. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8^th edition of the American Joint Committee on Cancer staging system. World J Gastroenterol 2019; 25(46): 6752-6766
URL: https://www.wjgnet.com/1007-9327/full/v25/i46/6752.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i46.6752

Chen HY, Wang X, Zhang H, Liu XB, Tan CL. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8^th edition of the American Joint Committee on Cancer staging system. World J Gastroenterol 2019; 25(46): 6752-6766 [PMID: 31857777 DOI: 10.3748/wjg.v25.i46.6752]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.